Tri Locum Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Tri Locum Partners's ASND Position: Q3 2026 in Review
Tri Locum Partners reduced its Ascendis Pharma (ASND) stake by 54% in Q3 2026, selling an estimated $35.6M and leaving 118,384 shares worth $27M. The position accounts for 5.33% of the portfolio, ranked #8.
Tri Locum Partners first reported a position in ASND in Q4 2022 and has held it in 11 quarters since. The position peaked at $69M in Q2 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Tri Locum Partners held 118,384 shares of Ascendis Pharma worth $27M as of Q3 2026.
- Tri Locum Partners sold 140,356 Ascendis Pharma shares in Q3 2026, an estimated $35.6M.
- Ascendis Pharma made up 5.33% of Tri Locum Partners's portfolio in Q3 2026, its #8 holding.
- Tri Locum Partners first reported a position in Ascendis Pharma in Q4 2022 and has held it in 11 quarters since.
- Tri Locum Partners's Ascendis Pharma position peaked at $69M in Q2 2026.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Tri Locum Partners's 13F filing for Q3 2026, filed 16 Nov 2026.